Patient selection
pulmonary tuberculoma, lung mucinous adenocarcinoma, PTB, calcification, cancer
CANCER, METASTASES
We retrospectively analyzed patients with lung mucinous adenocarcinoma and pulmonary tuberculoma diagnosed from January 2017 to November 2022 in The Fourth Affiliated Hospital of Hebei Medical University. The inclusion criteria of patients with PNMA and PTB were as follows: (1) surgical pathology-confirmed invasive mucinous adenocarcinoma (mucinous adenocarcinoma component > 90%) and pulmonary tuberculoma; (2) the maximum diameter of the nodule was less than or equal to 3.0 cm; (3) solitary and solid nodules without calcification, which may contain cavities or vacuoles and do not exhibit a ground glass density; and (4) complete clinical and pathological data, including analyzable plain and enhanced thin-slice CT image data (1.25 mm/slice) and available CT images within 2 weeks before the pathological diagnosis. The exclusion criteria of patients were as follows: (1) multiple pulmonary nodules; (2) antitumor therapy prior to CT examination and pathological diagnosis; (3) other types of cancer or incomplete clinical and imaging data; and (4) lymph node metastases and/or distant metastases [